During the forecast period 2023 to 2033, the global atrophic vaginitis treatment industry demand is expected to grow at a value of 8% CAGR, according to Future Market Insights. The market is likely to reach US$ 2.78 Billion in 2023, By the year 2033, the global market for Atrophic vaginitis treatment is expected to rise up to a market valuation of US$ 6 Billion. The atrophic vaginitis treatment market is expected to grow significantly in the coming years due to the increasing prevalence of the condition. According to a report published by the National Institutes of Health, approximately 50% of women experience vaginal dryness and discomfort after menopause, and around 10-40% of these women experience atrophic vaginitis. This translates to millions of women who are in need of proper treatment.
The market offers various treatment options, including hormone replacement therapy, topical estrogen creams, and vaginal moisturizers. Hormone replacement therapy is one of the most effective treatments for atrophic vaginitis. It involves taking hormones to replace the estrogen that the body is no longer producing. This treatment has been proven to reduce symptoms such as vaginal dryness, itching, and painful intercourse.
Get Sample Copy of Latest Reports! https://www.futuremarketinsights.com/reports/sample/rep-gb-16831
Topical estrogen creams are another popular treatment option. These creams are applied directly to the vagina and help to restore the natural moisture and elasticity of the vaginal tissues. They are easy to use and have been shown to be effective in relieving symptoms. Thus, with the availability of effective treatments, the atrophic vaginitis market is expected to grow in the upcoming years.
Key Takeaways from the Market Study:
- The global Atrophic vaginitis treatment market is expected to grow with an 8% CAGR during 2023 to 2033.
- By therapy type, Estrogen based therapy are expected to hold 53% of the market share in 2023 for Atrophic vaginitis treatment market.
- North America is expected to possess 48% market share for Atrophic vaginitis treatment market in 2023.
- Europe Atrophic vaginitis treatment market size is expected to possess 43% market share in 2023.
“The atrophic vaginitis treatment market is revolutionizing women’s health by providing effective solutions to a common condition that affects millions of women worldwide. With the increasing prevalence of the condition, the market is expected to grow significantly in the coming years. Despite the challenges faced by the industry” states an FMI analyst
Get In Touch With Our Analyst To Resolve Any Doubts You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-16831
Competitive Landscape:
Key players in the atrophic vaginitis treatment are Shionogi, Duchesnay, Hormos Medical, QuatRx Pharmaceuticals, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics, Inc.
- Shionogi is a pharmaceutical company that has developed a treatment for atrophic vaginitis called Intrarosa (prasterone). Intrarosa is a vaginal insert that contains the hormone dehydroepiandrosterone (DHEA), which is converted into estrogen in the body.
- Bayer HealthCare Pharmaceuticals Inc, a key player in the atrophic vaginitis treatment market is focusing on developing treatments for the ailment by researching and investing in developing therapies.
Key Segments Profiled in the Atrophic Vaginitis Treatment Industry Survey:
Diagnosis:
- Pelvic exam
- Urine test
- Acid balance test
Treatment:
- Vaginal moisturizers
- Water-based lubricants
Therapy Type:
- Estrogen based drugs
- Non-estrogen based drugs
Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Customization Unleashed: Learn How to Stand Out in a Competitive Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-16831
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube